Background: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gene expression analysis based on a custom made Affymetrix cancer array, we investigated the expression pattern of both primary and established pancreatic carcinoma cell lines. Methods: We analyzed the gene expression of 5 established pancreatic cancer cell lines (AsPC-1, BxPC-3, Capan-1, Capan-2 and HPAF II) and 5 primary isolates, 1 of them derived from benign pancreatic duct cells. Results: Out of 1,540 genes which were expressed in at least 3 experiments, we found 122 genes upregulated and 18 downregulated in tumor cell lines compared to benign cells with a fold change 1 3. Several of the upregulated genes (like Prefoldin 5, ADAM9 and E-cadherin) have been associated with pancreatic cancer before. The other differentially regulated genes, however, play a so far unknown role in the course of human pancreatic carcinoma. By means of immunohistochemistry we could show that thymosin ß-10 (TMSB10), upregulated in tumor cell lines, is expressed in human pancreatic carcinoma, but not in non-neoplastic pancreatic tissue, suggesting a role for TMSB10 in the carcinogenesis of pancreatic carcinoma. Conclusion: Using gene expression profiling of pancreatic cell lines we were able to identify genes differentially expressed in pancreatic adenocarcinoma, which might contribute to pancreatic cancer development.
The incidence has slightly increased over the past decades, being 8.1 for men and 5.4 for women in Germany [2] . About 80% of patients with pancreatic carcinoma present with an irresectable tumor at the time of diagnosis. Chemotherapy and radiation have not been able to increase the survival rate, and curability of the disease strongly depends on early diagnosis. Although several molecular alterations have been associated with pancreatic carcinoma, a much larger number of genes are involved in processes leading to cell transformation and, in consequence, pancreatic cancer.
DNA microarray technology has proven to be a useful tool to screen the differential mRNA expression pattern of normal and carcinoma cells [3] [4] [5] [6] [7] . While for other tumor entities a small piece from the tumor can be excised, homogenized and the mRNA extracted to be analyzed, the morphological growth peculiarities of pancreatic carcinoma impede this approach. Due to the characteristic host desmoplastic reaction to the tumor, only a small fraction of the mRNA extracted from carcinomatous tumor will descend from the transformed ductal cells. A majority will represent the expression profile of the surrounding stromal cells. Cell lines can, however, be used as model systems for tumor development and for the analysis of new treatment options. We therefore determined the differential gene expression in pancreatic carcinoma from established tumor cell lines and primary isolates using a custom made Affymetrix GeneChip. Within the set of genes we identified 140 genes as differentially expressed and validated the overexpression of thymosin ß-10 (TMSB10) within ductal pancreatic adenocarcinomas by immunohistochemistry.
Materials and Methods

Cell Lines and RNA Preparation
The ATCC (American Type Culture Collection) cell lines AsPC-1 (CRL-1682), BxPC-3 (CRL-1687), Capan-1 (HTB-79), Capan-2 (HTB-80) and HPAF II (CRL-1997) were a gift from Dr. M. Schmitz, Institute of Immunology, University of Dresden.
UKEAC-99 was obtained from a patient who underwent Whipple's operation for papillary carcinoma of intermediate differentiation [8] . PI3 was obtained from a metastasis in the omentum of a patient with pancreatic adenocarcinoma of intermediate differentiation. PI4 was derived from ascites fluid of a patient with pancreatic adenocarcinoma, and PI5 was obtained from a lung metastasis from a patient with pancreatic adenocarcinoma. All cell lines were tested for tumorigenicity and caused pancreatic adenocarcinoma after injection into mice which were histologically confirmed by a pathologist. Chromosomal analysis was performed with all cell lines.
ATCC cells and primary isolates were propagated in RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (Gibco), 2 mM glutamine (Gibco), nonessential amino acids (5 ml/l), and penicillin/streptomycin (10,000 units/ml penicillin and 10 mg/ml streptomycin, 10 ml/l medium; Sigma) and passaged before confluency.
The hPDC was obtained from the main pancreatic duct of a patient undergoing surgery for chronic pancreatitis. The cells were propagated in Keratinocyte SFM supplemented with 5 ng/ml EGF, 50 Ìg/ml BPE, 50 Ìg/ml gentamycin, 0.25 Ìg/ml Fungizone; 500 Ìl/ 60 mm dish (Invitrogen, Karlsruhe, Germany) [9] . All cells were lysed in a guanidine thiocyanate buffer with 2% ß-mercaptoethanol added (Promega, Heidelberg, Germany).
Poly A + RNA was prepared with a PolyATtract 1000 kit (Promega) according to the manufacturer's recommendations. For each sample the cDNA synthesis and in vitro transcription were performed according to the Affymetrix user manual using 500 ng of the isolated RNA. In brief, cDNA synthesis was initiated using the Affymetrix T7-oligo-dT promotor-primer combination at 0.1 mM. From this first strand cDNA, the second strand synthesis was generated with internal priming. The in vitro transcription was performed with Ambion's Megascript kit (Ambion, Huntington, UK), as recommended by the manufacturer. During the in vitro transcription, biotin-labeled nucleotides were incorporated into the aRNA. Hybridization and detection of the labeled aRNA on the metg001A GeneChip were performed according to Affymetrix's instructions.
Chip Design and Data Analysis
The custom metg001A GeneChip used in this study consists of 6,117 probe sets resembling 3,023 cDNA fragments. The cDNA fragments were chosen from a data mining approach to characterize the expression of cancers by an electronic Northern blot [10, 11] . In addition genes of signal transduction cascades, which are implicated in cancer development and progression, like the wnt cascade, were selected.
The background was computed as the mean of the 2% darkest feature intensities. After background correction the arrays were normalized by dividing each feature of a given GeneChip by the median value derived from all features of the same GeneChip. To generate the representative expression value we used the 75% quartile of the ranked intensities from the 20 perfect-matching oligonucleotides of a probe set, in an approach similar to that of Irizarry et al. [12] . To distinguish signal from noise we applied the Wilcoxon signed rank test to each probe set. The probe set was labeled as present if the result of the Wilcoxon signed rank was below 0.01.
To determine the relative difference in expression between the tumor cell lines and the benign ductal cells, the mean expression value in the tumor cell lines was calculated and compared to the expression value in the benign ductal cells. Genes were called as differentially expressed when the change fold was above 3 and when the gene was called present in at least 3 cell lines as well. Genes are listed according to the difference ratio.
Complete linkage clustering of the differentially expressed genes was done using the Genecluster/Treeview software package (http:// rana.lbl.gov/EisenSoftware.htm) using Spearman rank correlation as distance matrix ( fig. 1 ).
Immunohistochemical Staining
Tumor tissue was selected from 55 consecutive cases of pancreatic ductal adenocarcinoma, whereas adenocarcinoma of the ampulla Alldinger et al.
of Vater or the distal ductus choledochus was not included. Patients were operated on at ages from 34 to 80 years; 27 were male and 28 were female.
Four-micron sections were cut from the formalin-fixed, paraffinembedded, pancreatic adenocarcinoma tissue. The sections were mounted on superfrost slides (Menzel Gläser, Braunschweig, Germany), dewaxed with xylene and gradually hydrated. Antigen was exposed by heating the sections under high pressure in Tris-EDTAcitrate buffer. The primary goat polyclonal anti-human TMSB10 antibody [13] was diluted 1:500 in PBS containing 2% horse serum (Vector Laboratories, Burlingame, Calif., USA). After incubation for 45 min, the reaction was visualized with a biotinylated anti-goat antibody (5 Ìg/ml, Vector Laboratories) and avidin-biotin-peroxidase (ABC ELITE, Vector Laboratories). Diaminobenzidine served as chromogen. Afterwards the slides were briefly counterstained with hematoxylin. The primary antibody was omitted for the negative control. Unspecific goat IgG at the same concentration as the specific Ig were used as isotype controls to assure the specificity of the reaction. Staining intensity was evaluated semi-quantitatively as negative, weak, moderate or strong. The final results, however, were recorded as positive or negative staining only.
Results
Out of the 3,023 cDNA fragments interrogated by gene expression profiling 1,540 genes were rated as present in at least 3 cell lines. Difference in expression was rated significant if the ratio was greater than 3 and if the gene was detected as present in at least 3 cell lines as well. Of the 1,540 genes, 122 were upregulated and 18 were downregulated in respect to the benign cells. Seven genes were upregulated and 3 genes downregulated in primary isolates only. One gene was upregulated in ATCC cell lines only and not in primary isolates (table 1) .
Using hierarchical clustering, we generated a heat map of the gene expression of the identified genes to visualize the gene expression within each experiment ( fig. 1 ). Genes encoding proteins of known function have been classified according to functional categories ( fig. 2 ). Within these categories we found that genes associated with cellular proliferation are commonly upregulated. Within the 122 genes we identified several genes, such as ADAM9 or Ecadherin, with known function in carcinoma of the pancreas or other tissues (table 2). Alldinger et al. Alldinger et al. The fold change of expression of the tumor cell lines vs. the cell line hPDC. MV/hPDC = fold change of the mean of the expression value of the tumor cell lines vs. hPDC. Overexpression of TMSB10 in Human Pancreatic Carcinoma Expression changes observed in cell lines are not necessarily represented in primary tissues also. Therefore, out of the 122 upregulated genes we selected TMSB10 to analyze the expression of its protein in human pancreatic adenocarcinoma by using a polyclonal antibody and immunohistochemistry. Moreover, TMSB10 is associated with cellular proliferation in a number of cancers indicating that overexpression of this gene might be a causal event [13] .
TMSB10 expression was detected in endothelium, smooth muscle cells, neuronal cells, and strongly in macrophages, both in tumor and in normal tissues. In 49 of the 54 (90.7%) ductal adenocarcinomas examined, immunoreactivity for TMSB10 was detected in the tumor cells ( fig. 3) . Conversely, in none of the 10 sections of normal pancreatic tissue could TMSB10 be shown by means of immunohistochemistry. In 24 of 54 (44.4%) cases, we detected staining in the stroma. The correlation between staining in the tumor and staining in stroma cells, which was not significant, is shown in table 3. Furthermore, we could not find a significant correlation between the positivity or the intensity of expression of TMSB10 and postoperative survival of patients. However, we observed that TMSB10 is highly expressed within well-and poorly-differentiated carcinomas (G1 and G3), whereas the majority of moderately differentiated tumors (G2) expressed TMSB10 only moderately.
Alldinger et al.
Discussion
The DNA microarray technology is widely used as a powerful tool to investigate the mRNA expression pattern of various tissues and cell types. For tissues that are difficult to access or scarcely available, cell lines are a helpful alternative. This is especially true for pancreatic cancer. It is well known that cells change both their morphology and their expression pattern when isolated from their parent organism, the human body [14, 15] . However, analysis of cell lines might circumvent the need for microdissection of tissues and, furthermore, allow the characterization of the most adequate model system for further analysis of differentially expressed genes.
Upregulation of growth factors, cytokines, receptors, extracellular matrix proteins and numerous other proteins is a common event in carcinogenesis. We corroborated this in the pancreatic tumor cell lines analyzed in this study, finding 122 genes upregulated and only 18 downregulated in respect to benign cells.
Apart from the genes differentially regulated in all cell lines, we found 7 genes upregulated and 3 genes downregulated in the primary isolates only, while 1 gene, frizzled 6, was upregulated only in the ATCC cell lines. E-cadherin, 1 of the 3 genes downregulated in primary cells, is the main adhesion molecule of epithelia, and it has been implicated in carcinogenesis because it is frequently lost in human epithelial cancers [16] . It is known to act as a strong invasion suppressor in experimental tumor cell systems [17] . Partial or complete loss of E-cadherin expression correlates with malignancy in human cancers [18] . Interestingly, we found downregulation in the primary isolates, but not in the ATCC cells, which may support the assumption that primary cell lines reflect the biological features of the tumor more than established cell lines.
The mesenchymal intermediate filament marker vimentin is strongly expressed in invasive pancreatic carcinomas [19] and generally expressed in pancreatic carcinoma cell lines [20] . The overexpression in primary isolates suggests a relative importance of this filament in cells adapting to the new environment petridish; it seems to be of less importance after adjustment to the different needs of the cells in vitro. Most genes, however, show a comparable degree of expression. This might support the assumption that cells adapt very quickly when isolated and transferred into medium. If they would not, they could not replicate and survive. Within the large set of genes implied in cellular proliferation and identified by the GeneChip analysis we were especially interested in the analysis of TMSB10. The ß-thymosins are a family of related peptides known to be present in a wide variety of mammalian and other vertebrate cells and tissues. TMSB10 mRNA is overexpressed in germ cell tumors of different histological types, breast-, ovarian-, uterine carcinomas, colon, thyroid and esophageal carcinoma cell lines [13, 21, 22] . It has also been shown that TMSB10 plays a critical role in the regulation of anchorage-independent growth and assembly of actin filaments [23] . Furthermore upregulation of TMSB10 was identified in the breast cancer cell line MCF-7 in the course of treatment with 5-fluorouracil, tomudex and oxaliplatin, respectively. TMSB10 expression is also elevated in the 5-fluorouracil-resistant colon cancer cell line H630R10 [24] implying a role for TMSB10 within the reaction of cells on toxic compounds.
In conclusion we have reported for the first time the expression of TMSB10 in pancreatic carcinoma. TMSB10 might play a general role in human carcinogenesis and in pancreatic carcinomas especially. Our finding that TMSB10 is strongly expressed in stroma cells of pancreatic carcinoma supports the suggestion of Santelli et al. [23] who claim a critical role for TMSB10 in the regulation of anchorage-independent growth and assembly of actin filaments.
